Cargando…

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signaling

Ovarian clear-cell carcinoma (OCCC) is an aggressive form of ovarian cancer with high ARID1A mutation rates. Here we present a mutant mouse model of OCCC. We find that ARID1A inactivation is not sufficient for tumor formation, but requires concurrent activation of the phosphoinositide 3-kinase catal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandler, Ronald L., Damrauer, Jeffrey S., Raab, Jesse R., Schisler, Jonathan C., Wilkerson, Matthew D., Didion, John P., Starmer, Joshua, Serber, Daniel, Yee, Della, Xiong, Jessie, Darr, David B., Pardo-Manuel de Villena, Fernando, Kim, William Y., Magnuson, Terry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308813/ https://www.ncbi.nlm.nih.gov/pubmed/25625625 http://dx.doi.org/10.1038/ncomms7118

Ejemplares similares

Global gene expression profiling of a mouse model of ovarian clear cell carcinoma caused by ARID1A and PIK3CA mutations implicates a role for inflammatory cytokine signaling
por: Chandler, Ronald L., et al.
Publicado: (2015)

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
por: Anabel Sinberger, Liat, et al.
Publicado: (2023)

Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma
por: Zhou, Huan, et al.
Publicado: (2019)

Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis
por: Reske, Jake J., et al.
Publicado: (2021)

Detecting broad domains and narrow peaks in ChIP-seq data with hiddenDomains
por: Starmer, Joshua, et al.
Publicado: (2016)

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers
por: Janku, Filip, et al.
Publicado: (2011)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
por: Manca, Antonella, et al.
Publicado: (2015)

The Mouse INO80 Chromatin-Remodeling Complex Is an Essential Meiotic Factor for Spermatogenesis
por: Serber, Daniel W., et al.
Publicado: (2015)

Interactome determination of a Long Noncoding RNA implicated in Embryonic Stem Cell Self-Renewal
por: Smith, Keriayn N., et al.
Publicado: (2018)

PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
por: Payne, S N, et al.
Publicado: (2015)

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
por: Murakami, Kosuke, et al.
Publicado: (2021)

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
por: Suryo Rahmanto, Yohan, et al.
Publicado: (2020)

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression
por: Choi, Jae Yoon, et al.
Publicado: (2017)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

Coexisting Papillary and Clear Renal Cell Carcinoma in the Same Kidney
por: Ustuner, Murat, et al.
Publicado: (2014)

EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation
por: Mu, Weipeng, et al.
Publicado: (2018)

PIK3CA Cooperates with KRAS to Promote MYC Activity and Tumorigenesis via the Bromodomain Protein BRD9
por: Bell, Catherine M., et al.
Publicado: (2019)

Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer
por: Hao, Yujun, et al.
Publicado: (2022)

Phosphorylation at tyrosine 317 and 508 are crucial for PIK3CA/p110α to promote CRC tumorigenesis
por: Wang, Ting, et al.
Publicado: (2023)

Uncovering the dosage-dependent roles of Arid1a in gastric tumorigenesis for combinatorial drug therapy
por: Loe, Adrian Kwan Ho, et al.
Publicado: (2021)

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
por: Maeda, Daichi, et al.
Publicado: (2010)

Nucleolar Association and Transcriptional Inhibition through 5S rDNA in Mammals
por: Fedoriw, Andrew M., et al.
Publicado: (2012)

Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer
por: Ibarrola-Villava, Maider, et al.
Publicado: (2015)

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
por: Berns, Katrien, et al.
Publicado: (2018)

Pro-tumorigenic roles of TGF-β signaling during the early stages of liver tumorigenesis through upregulation of Snail
por: Moon, Hyuk, et al.
Publicado: (2017)

Tumor-associated myeloid cells promote tumorigenesis of non-tumorigenic human and murine prostatic epithelial cell lines
por: Sass, Stephanie N., et al.
Publicado: (2018)

SNP array profiling of mouse cell lines identifies their strains of origin and reveals cross-contamination and widespread aneuploidy
por: Didion, John P, et al.
Publicado: (2014)

Identification and Validation of PIK3CA as a Marker Associated with Prognosis and Immune Infiltration in Renal Clear Cell Carcinoma
por: Li, Ya, et al.
Publicado: (2021)

Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation
por: Kalantry, Sundeep, et al.
Publicado: (2009)

KDM6 Demethylase Independent Loss of Histone H3 Lysine 27 Trimethylation during Early Embryonic Development
por: Shpargel, Karl B., et al.
Publicado: (2014)

Repression of the soma-specific transcriptome by Polycomb-repressive complex 2 promotes male germ cell development
por: Mu, Weipeng, et al.
Publicado: (2014)

Histone H3.3 maintains genome integrity during mammalian development
por: Jang, Chuan-Wei, et al.
Publicado: (2015)

P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis
por: McHenry, Peter R, et al.
Publicado: (2010)

BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress‐related tumorigenicity
por: Takemoto, Kenshiro, et al.
Publicado: (2022)

Prevention of tumorigenesis in mice by exercise is dependent on strain background and timing relative to carcinogen exposure
por: Kelly, Scott A., et al.
Publicado: (2017)

Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
por: Yuan, W, et al.
Publicado: (2013)

FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells
por: Zhang, Yanchun, et al.
Publicado: (2022)

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma
por: Morikawa, Asuka, et al.
Publicado: (2018)

Mining database and verification of PIK3CB as a marker predicting prognosis and immune infiltration in renal clear cell carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fc77bl8f053bcagn9oid17j1ol